Support of Gut Barrier Function

"Support of gut barrier function" does not refer to a specific molecule or receptor but rather describes the overall maintenance and enhancement of the intestinal epithelial and vascular barriers. These barriers are composed primarily of enterocytes joined by complex structures including tight junctions (TJs), adherens junctions (AJs), mucins such as MUC2, and other associated proteins. The integrity and regulation involve multiple signaling pathways—such as those mediated by myosin light chain kinase (MLCK), nuclear factor kappa B (NFκB), mitogen activated protein kinases (MAPK), sphingosine 1-phosphate receptor 1 (S1PR1)—and can be disrupted in diseases like inflammatory bowel disease or sepsis. Therapeutic strategies aimed at supporting this function typically target these underlying molecules/pathways rather than "gut barrier support" itself[1][3].

Other names

Support of gut barrier function is not a molecular target; it refers to a physiological process or therapeutic goal rather than a specific molecule, receptor, enzyme, or protein.

Mechanisms include inhibition of MLCK to prevent tight junction disruption, activation of S1PR1 to enhance vascular integrity, and modulation of inflammatory pathways such as NFκB and MAPK